The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,005,344 in first-year total cost, median $330,186.
Most frequent study sections
- Cancer Biomarkers Study Section[CBSS]1
- Chemo/Dietary Prevention Study Section[CDP]1
- Tumor Progression and Metastasis Study Section[TPM]1
Most frequent institutions
- CLEVELAND CLINIC LERNER COM-CWRU1
- UNIVERSITY OF CALIFORNIA RIVERSIDE1
- UNIVERSITY OF SOUTH ALABAMA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | MicroRNA and colorectal cancer chemoprevention1R01CA192395-01A1 | XI, YAGUANG | UNIVERSITY OF SOUTH ALABAMA, AL | $346,270 | CDP |
| 2015 | 3-Dimensional profile of circulating miRNA for early cancer detection1R01CA188991-01A1 | ZHONG, WENWAN | UNIVERSITY OF CALIFORNIA RIVERSIDE, CA | $330,186 | CBSS |
| 2014 | Tissue Specific Regulation of Diabetes-Associated Cancer Growth1R01CA177771-01A1 | STENINA, OLGA I | CLEVELAND CLINIC LERNER COM-CWRU, OH | $328,888 | TPM |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.